Clinical trial
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With…
NCT00002768 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00002768 |
|---|---|
| Title | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission |
| Official title | AUTOLOGOUS STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA IN SECOND REMISSION: A PHASE II STUDY |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, busulfan, cytarabine, etoposide, methotrexate, peripheral blood stem cell transplantation |
| Enrollment | 51 |
| Start date | Jun 1, 1996 |
| Primary completion | Feb 1, 2003 |
| Completion | Mar 1, 2009 |
| First posted | Apr 22, 2004 |
| Last update posted | Jun 28, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: